Dr Lalchandani Labs Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI's depositories and participants regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the compliance certificate on April 09, 2026, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations, 2018. Managing Director Arjan Lal Chandani signed the submission letter, which was addressed to BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.

Certificate Confirmation by Registrar

Cameo Corporate Services Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate dated April 09, 2026. The certificate confirms that all securities received from depository participants for dematerialisation during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories.

Compliance Verification Details

The registrar confirmed several key compliance aspects in their certificate:

• Securities received for dematerialisation were accepted or rejected and confirmed to depositories
• All securities comprised in the certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were mutilated and cancelled after due verification by the depository participant
• Names of depositories were substituted in the register of members as registered owners within stipulated time limits

Corporate Information

The filing was signed by Arjan Lal Chandani, Managing Director with DIN 07014579. Cameo Corporate Services Limited, with CIN U67120TN1998PLC041613, operates from Subramanian Building, Club House Road, Chennai, and serves as the company's share transfer agent for processing dematerialisation activities and maintaining compliance with SEBI regulations.

Bandhan AMC Limited has announced the declaration of dividend for its Large & Mid Cap Fund under the Income Distribution cum Capital Withdrawal Option (IDCW), marking a positive development for investors. The Board of Directors of Bandhan Mutual Fund Trustee Limited has approved this dividend distribution with specific terms and conditions.

Dividend Declaration Details

The dividend has been approved with the record date set as Tuesday, March 10, 2026. The declaration is subject to availability of distributable surplus and follows regulatory compliance requirements. The fund, formerly known as Bandhan Core Equity Fund, offers different dividend rates for Regular and Direct plans.

The NAV figures are as on March 04, 2026, with a face value of ₹10 per unit for both plans.

Eligibility and Important Conditions

All investors whose names appear in the register of unit holders of the scheme/plan/option as on the close of the record date will be eligible to receive the dividend. The company has specified that TDS and other statutory levies will be applicable on the amount received by investors.

Considering the volatile nature of markets, the Trustee reserves the right to restrict the quantum of dividend up to the per unit distributable surplus available on the record date in case of market fall. If the record date falls on a non-business day, the immediately following business day shall be deemed to be the record date.

Post-Dividend Impact

Pursuant to the payment of dividend, the NAV of the scheme/plan/option will fall to the extent of payout and statutory levy, if any. This is a standard practice in mutual fund dividend distributions where the NAV adjusts to reflect the dividend payment.

The notice was dated March 05, 2026, and includes the standard disclaimer that mutual fund investments are subject to market risks, advising investors to read all scheme-related documents carefully before investing.